Conducting clinical trials during the COVID-19 pandemic

Erin K Collier1, Jennifer L Hsiao2, Vivian Y Shi3

  • 1David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Insights

The COVID-19 pandemic disrupted dermatology clinical trials. This study offers strategies to ensure compliant and safe research conduct during the public health crisis.

Area of Science:

  • Dermatology
  • Clinical Research
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted dermatology clinical trial operations.
  • Governmental and institutional shutdowns, along with new restrictions, created unprecedented challenges for ongoing research.

Purpose of the Study:

  • To identify the challenges faced by dermatology clinical trials during the COVID-19 pandemic.
  • To propose strategies for maintaining compliant and safe research conduct amidst the pandemic.

Main Methods:

  • Review of operational impacts of the COVID-19 pandemic on dermatology clinical trials.
  • Identification of key challenges in maintaining research integrity and participant safety.
  • Development of actionable strategies for compliant and safe trial conduct.

Main Results:

  • Dermatology trials faced significant operational hurdles due to pandemic-related restrictions.
  • Maintaining research compliance and ensuring the safety of staff and participants were primary concerns.
  • Specific strategies are needed to navigate these challenges effectively.

Conclusions:

  • The COVID-19 pandemic necessitated adaptive strategies in dermatology clinical trials.
  • Implementing robust safety protocols and flexible operational plans is crucial.
  • Ensuring continued, compliant research is vital for advancing dermatological science.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
84
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
778
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
330